Medicskin Holdings Ltd. (HK:8307)

:8307

8307

Medicskin Holdings Ltd.

RESEARCH TOOLSreports

Medicskin Holdings Ltd. (8307) Price & Analysis

0 Followers

8307 Stock Chart & Stats

HK$0.17

HK$0.00(0.00%)

At close: Nov 11 4:00 PM EST

HK$0.17

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.02 - HK$0.24

Previous CloseN/A

Volume16.00K

Average Volume (3M)24.27K

Market Cap

HK$56.73M

Enterprise ValueHK$51.47M

Total Cash (Recent Filing)HK$25.16M

Total Debt (Recent Filing)HK$19.89M

Price to Earnings (P/E)362.7

Beta0.83

Next Earnings

Jun 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding396,736,000

10 Day Avg. Volume55,600

30 Day Avg. Volume24,266

Financial Highlights & Ratios

PEG Ratio-2.09

Price to Book (P/B)17.50

Price to Sales (P/S)1.63

P/FCF Ratio8.86

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Operating Cash Flow StrengthRising operating cash flow to HKD 9.13M indicates durable internal liquidity and cash generation. This reduces near-term refinancing needs, supports working capital and routine capex, and provides a buffer for strategic actions even while earnings remain negative.

Stable EBITDA Margin ExpansionA modest improvement in EBITDA margin shows the company is tightening operating efficiencies and controlling recurring costs. Sustained margin stability increases the likelihood that future revenue stabilization could translate to positive operating cash flows and eventual profitability.

Strong Cash Conversion Despite LossesEfficient cash conversion despite accounting losses suggests good working-capital management and limited cash burn. This strength gives the business runway to address structural issues and reduces dependence on immediate external capital, a durable advantage over the medium term.

Bears Say

High Financial LeverageA debt-to-equity ratio of 5.44 and thin equity ratio materially limit financial flexibility. High leverage raises refinancing and interest risks, constrains ability to invest in growth, and makes the company vulnerable to cash-flow shocks over the coming months.

Sharp Gross Margin DeteriorationA sustained gross margin decline of ~30 percentage points signals structural cost pressures or pricing weakness. Lower gross margins reduce core earning power and leave less room to absorb SG&A, making recovery of profitability harder without clear revenue or cost fixes.

Persistent UnprofitabilityThree years of negative net margins erode equity and limit internal funding for growth. Continued losses increase reliance on external financing, complicate strategic investment, and heighten execution risk for any turnaround plans over the medium term.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$56.73M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Jun 22, 2026 which is in 75 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Nov 24, 2025. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -23.684%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Ltd. (8307) is a leading healthcare company specializing in advanced dermatological and aesthetic solutions. The company operates in the medical and cosmetic sectors, offering a range of products and services designed to enhance skin health and appearance. Medicskin is known for its innovative skincare products, medical devices, and aesthetic treatments, catering to both consumers and healthcare professionals.